The new crown vaccine will be available at the end of the year

Liu Jingzhen, Secretary of the CPC Committee and chairman of the board of directors of sinopharma group, said that after the completion of the phase III international clinical trial, the new crown inactivated vaccine can enter the examination and approval process, and it is expected that it will be put on the market by the end of December this year. It is estimated that the annual output of inactivated vaccine of Beijing Institute of biological products will reach 120 million doses, and that of Wuhan Institute of biological products will reach 100 million doses. In addition, the genetic engineering subunit vaccine is expected to enter clinical research in October this year, and once the research and development is successful, it will be able to rapidly mass produce.